Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Income from Non-Controlling Interests (2022 - 2025)

Historic Income from Non-Controlling Interests for Arrowhead Pharmaceuticals (ARWR) over the last 9 years, with Q4 2025 value amounting to -$2.6 million.

  • Arrowhead Pharmaceuticals' Income from Non-Controlling Interests fell 2044.07% to -$2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $31.3 million, marking a year-over-year increase of 41879.65%. This contributed to the annual value of $31.7 million for FY2025, which is 41122.55% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Income from Non-Controlling Interests of -$2.6 million as of Q4 2025, which was down 2044.07% from $39.9 million recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests ranged from a high of $39.9 million in Q3 2025 and a low of -$3.4 million during Q2 2025
  • Moreover, its 4-year median value for Income from Non-Controlling Interests was -$1.9 million (2024), whereas its average is $1.0 million.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first tumbled by 41687.24% in 2023, then soared by 151990.74% in 2025.
  • Arrowhead Pharmaceuticals' Income from Non-Controlling Interests (Quarter) stood at -$486000.0 in 2022, then crashed by 416.87% to -$2.5 million in 2023, then rose by 15.09% to -$2.1 million in 2024, then dropped by 20.44% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q4 2025, $39.9 million for Q3 2025, and -$3.4 million during Q2 2025.